After our discovery, several studies confirmed the causal role of SLFN11 in the process of cell death upon DDA treatment in cell lines (10, 11), organoids (5), and xenografts (3, 4, 6) from different tumor types. This evidence concerns the gene SLFN11 and neoplasm.